Ziopharm Oncology (ZIOP) Misses Q4 EPS by 1c

March 2, 2020 4:10 PM EST

Ziopharm Oncology (NASDAQ: ZIOP) reported Q4 EPS of ($0.09), $0.01 worse than the analyst estimate of ($0.08).

For earnings history and earnings-related data on Ziopharm Oncology (ZIOP) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings